Literature DB >> 2452326

Clonal analysis of the actions of the murine leukemia inhibitory factor on leukemic and normal murine hemopoietic cells.

D Metcalf1, D J Hilton, N A Nicola.   

Abstract

The in vitro actions of leukemia inhibitory factor (LIF) purified from Krebs tumor conditioned medium, were analyzed on murine leukemic M1 and WEHI-3B D+ cells and on normal hemopoietic progenitor cells. LIF has no observable effects on WEHI-3B D+ cells but rapidly induced macrophage differentiation and loss of clonogenicity in M1 cells, resulting in the formation of abortive clones or differentiating colonies of reduced size and number. These effects were observable within one to two cell divisions in the presence of LIF and were irreversible. Addition of macrophage-colony-stimulating factor (CSF) but not granulocyte/macrophage-CSF, granulocyte-CSF, or multi-CSF reduced the LIF-induced suppression of colony numbers and size. G-CSF had a slower differentiation-inducing action on M1 cells than LIF but potentiated the differentiation-inducing effects of low concentrations of LIF. LIF had no colony-stimulating activity for normal granulocyte-macrophage progenitor cells and did not alter their quantitative responsiveness to CSF. However, culture of normal progenitor cells in the presence of LIF, but initial absence of CSF, reduced the survival of these cells. The differing actions of LIF and G-CSF on M1 leukemic cells suggest the existence of distinct mechanisms for inducing macrophage differentiation in these leukemic cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2452326

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  16 in total

1.  Biological inducers of haemopoietic differentiation.

Authors:  S Eridani; E Abood
Journal:  Cytotechnology       Date:  1991-02       Impact factor: 2.058

2.  Murine hematopoietic stem cells committed to macrophage/dendritic cell formation: stimulation by Flk2-ligand with enhancement by regulators using the gp130 receptor chain.

Authors:  D Metcalf
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

3.  Leukemia inhibitory factor protects against experimental lethal Escherichia coli septic shock in mice.

Authors:  P M Waring; L J Waring; T Billington; D Metcalf
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

4.  Leukemia inhibitory factor is expressed in cartilage and synovium and can contribute to the pathogenesis of arthritis.

Authors:  M Lotz; T Moats; P M Villiger
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

5.  A major binding protein for leukemia inhibitory factor in normal mouse serum: identification as a soluble form of the cellular receptor.

Authors:  M J Layton; B A Cross; D Metcalf; L D Ward; R J Simpson; N A Nicola
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

6.  Specific binding of murine leukemia inhibitory factor to normal and leukemic monocytic cells.

Authors:  D J Hilton; N A Nicola; D Metcalf
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

7.  Design of the artificial acellular feeder layer for the efficient propagation of mouse embryonic stem cells.

Authors:  Masato Nagaoka; Yuko Hagiwara; Keiko Takemura; Yuta Murakami; Jixuan Li; Stephen A Duncan; Toshihiro Akaike
Journal:  J Biol Chem       Date:  2008-07-09       Impact factor: 5.157

8.  An anti-inflammatory role for leukemia inhibitory factor receptor signaling in regenerating skeletal muscle.

Authors:  Liam C Hunt; Aradhana Upadhyay; Jalal A Jazayeri; Elizabeth M Tudor; Jason D White
Journal:  Histochem Cell Biol       Date:  2012-08-28       Impact factor: 4.304

9.  Leukemia inhibitory factor levels are elevated in septic shock and various inflammatory body fluids.

Authors:  P Waring; K Wycherley; D Cary; N Nicola; D Metcalf
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

10.  Opposing effects of tumor necrosis factor alpha and leukemia inhibitory factor in lipopolysaccharide-stimulated myelopoiesis.

Authors:  R Kreisberg; M S Detrick; R N Moore
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.